A rare gastrointestinal cancer is rising sharply among Gen X and Millennials, prompting experts to call for more research.

The expansion of cancer research in the Newark region will also be heightened through the relationship with the Rutgers New ...

Experts worry about the uptick in cases as more Gen Xers and millennials are being diagnosed with a variety of ...

The FDA has approved a revised label for Merck’s immunotherapy drug Keytruda, limiting its use in some gastrointestinal cancer treatments to patients whose tumors express a minimum level of PD-L1 ...

CANCER is typically thought of as a disease of old age. But doctors are increasingly finding that certain types, particularly bowel cancer, are hitting younger people far more than they used to.

Doctors are reporting a surprising increase in appendix cancer rates among millennials and Generation X, indicating that a ...

Researchers at Seoul National University Hospital applied 'Enhanced Recovery After Surgery (ERAS)' to gastric cancer surgery ...